Pharmaceutical giant Eli Lilly announced Monday it will acquire Loxo Oncology for around $8 billion, the latest big transaction aimed at developing and monetizing new treatments for cancer.
Jan 7, 2019
0
0
Federal health experts say a diabetes drug from Novo Nordisk should be approved for a new use in treating obesity.
Sep 11, 2014
0
0
A new scoring system takes a holistic view of the effect of obesity treatment in patients.
Apr 23, 2013
0
0
Patients with type 2 diabetes who tailor their own treatment in cooperation with their doctor can reduce their risk of complications such as heart attack with up to 20 percent. This is the result of a new Danish study from ...
Apr 8, 2013
0
0
(HealthDay) -- Treatment of type 2 diabetes should be personalized in a patient-centered approach, with diet, exercise, and education forming the basis of any treatment program, supplemented by medications as necessary, according ...
Apr 23, 2012
0
0
The investigational drug ganetespib, a synthetic second-generation Hsp90 inhibitor, slowed the growth of cancer cells taken from non-small cell lung cancer tumors with a mutation in the KRAS gene. The drug was even more active ...
Jan 11, 2012
0
0
Linagliptin (trade name: Trajenta) has been approved since August 2011 to improve blood glucose control ("glycaemic control") in adults with type 2 diabetes mellitus whose elevated blood glucose levels are inadequately controlled ...
Jan 6, 2012
0
0
Whether patients with type 2 diabetes mellitus benefit from attempts to lower their blood glucose levels to near-normal levels through treatment ("intensive blood glucose control") remains an unanswered question. The studies ...
Jul 14, 2011
0
0
